Career history of Iain W. Duncan
Former positions of Iain W. Duncan
Companies | Position | Start | End |
---|---|---|---|
Horizon Therapeutics, Inc.
Horizon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Horizon Therapeutics is a late stage biopharmaceutical company focused on the development of prescription drugs for mild to moderate pain relief. It is creating novel therapies through innovative combinations of existing pharmaceutical products. The Company is building a portfolio of proprietary formulations that seek to improve safety, efficacy, and patient compliance. | Chief Operating Officer | 2009-12-27 | 2010-04-04 |
Corus Pharma, Inc.
Corus Pharma, Inc. Pharmaceuticals: MajorHealth Technology Corus Pharma, Inc. develops drugs to treat needs in infectious diseases and respiratory areas. The firm's core competencies reside in the identification of drugs, rapid clinical development, and FDA approval of its products. The firm was founded in January 2001 by A. Bruce Montgomery and is headquartered in Seattle, WA. | Chief Operating Officer | 2008-12-03 | 2008-12-03 |
Founder | 2008-12-03 | 2008-12-03 | |
Lyondell Chemical Co.
Lyondell Chemical Co. Finance/Rental/LeasingFinance Lyondell Chemical Co. manufactures and distributes chemicals & plastics, produces fuel products, and refines heavy & high-sulfur crude oil. The company operates in four segments: Ethylene Co-Products and Derivatives, Propylene Oxide & Related Products, Refining, and Inorganic Chemicals. The company's products are used in the clothing, food packaging, household furnishings, automotive parts, construction, home-building materials, paints, and coating industries. The company was founded in 1985 and is headquartered in Houston, TX. | Corporate Officer/Principal | - | - |
PathoGenesis Corp
PathoGenesis Corp BiotechnologyHealth Technology Part of Novartis AG, PathoGenesis Corp is a company that develops and markets innovative treatments for chronic infectious diseases. The company is based in Seattle, WA. The company was founded by Isaac Blech. PathoGenesis was acquired by Chiron Corp. on September 19, 2000 for $639.75 million. | Corporate Officer/Principal | - | - |
Training of Iain W. Duncan
Trent University | Undergraduate Degree |
Statistics
International
United States | 5 |
Canada | 2 |
Operational
Corporate Officer/Principal | 2 |
Chief Operating Officer | 2 |
Undergraduate Degree | 1 |
Sectoral
Health Technology | 4 |
Consumer Services | 2 |
Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 4 |
---|---|
Horizon Therapeutics, Inc.
Horizon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Horizon Therapeutics is a late stage biopharmaceutical company focused on the development of prescription drugs for mild to moderate pain relief. It is creating novel therapies through innovative combinations of existing pharmaceutical products. The Company is building a portfolio of proprietary formulations that seek to improve safety, efficacy, and patient compliance. | Health Technology |
PathoGenesis Corp
PathoGenesis Corp BiotechnologyHealth Technology Part of Novartis AG, PathoGenesis Corp is a company that develops and markets innovative treatments for chronic infectious diseases. The company is based in Seattle, WA. The company was founded by Isaac Blech. PathoGenesis was acquired by Chiron Corp. on September 19, 2000 for $639.75 million. | Health Technology |
Lyondell Chemical Co.
Lyondell Chemical Co. Finance/Rental/LeasingFinance Lyondell Chemical Co. manufactures and distributes chemicals & plastics, produces fuel products, and refines heavy & high-sulfur crude oil. The company operates in four segments: Ethylene Co-Products and Derivatives, Propylene Oxide & Related Products, Refining, and Inorganic Chemicals. The company's products are used in the clothing, food packaging, household furnishings, automotive parts, construction, home-building materials, paints, and coating industries. The company was founded in 1985 and is headquartered in Houston, TX. | Finance |
Corus Pharma, Inc.
Corus Pharma, Inc. Pharmaceuticals: MajorHealth Technology Corus Pharma, Inc. develops drugs to treat needs in infectious diseases and respiratory areas. The firm's core competencies reside in the identification of drugs, rapid clinical development, and FDA approval of its products. The firm was founded in January 2001 by A. Bruce Montgomery and is headquartered in Seattle, WA. | Health Technology |
- Stock Market
- Insiders
- Iain W. Duncan
- Experience